New liquid biopsy technique detects prostate cancer disease evolution
Researchers studied 53 patients with metastatic castration-resistant prostate cancer undergoing hormone therapy or chemotherapy.
Cancer
ExThera’s device reduces pancreatic cancer cells from blood
Pangea’s AI imaging platform predicts cancer treatment response
OncoBeta’s Rhenium-SCT skin cancer therapy rolled out in Madrid clinic
ASCO24: Precede Biosciences assay classifies HER2 and ER status in cancers
NovaScan selects Epredia to distribute MarginScan device in US
QT imaging’s breast imaging system proves as effective as mammography
Prothea debuts with $13m to develop cancer diagnostics and treatment
